Breaking News Instant updates and real-time market news.

TXMD

TherapeuticsMD

$5.63

0.06 (1.08%)

06:58
07/17/17
07/17
06:58
07/17/17
06:58

TherapeuticsMD reports results of meeting with FDA regarding NDA for TX-004HR

TherapeuticsMD announced a regulatory update regarding the New Drug Application, or NDA, for TX-004HR, the company's investigational applicator-free estradiol vaginal softgel capsule for the treatment of moderate-to-severe vaginal pain during sexual intercourse, a symptom of vulvar and vaginal atrophy due to menopause. On June 14 the Company participated in a Type A Post-Action Meeting with the Division of Bone, Reproductive, and Urologic Products of the FDA to discuss the Complete Response Letter that the Company previously received for the NDA for TX-004HR. The meeting enabled the Company to present new information that the Company believes could address concerns raised by the FDA in the CRL and positively affect the status of the NDA for TX-004HR. The Company has received the minutes of the meeting and, per the FDA's request, has formally submitted the new information for consideration related to the NDA for TX-004HR. The Company expects to have additional clarity on the pathway forward for the NDA for TX-004HR in the coming weeks.

TXMD TherapeuticsMD
$5.63

0.06 (1.08%)

06/13/17
JEFF
06/13/17
NO CHANGE
JEFF
TherapeuticsMD could use data to push post-approval study, says Jefferies
Jefferies analyst Matthew Andrews says that TherapeuticsMD could use prior data - including a finding that low-dose vaginal estrogen is safe for women with breast cancer and a finding that estrogen delivered in a patch is safe for two years - to convince an FDA panel to allow the company to address concerns raised in a complete response letter for its TX-004 drug with a post-approval study instead of a pre-approval study. Andrews keeps a $15 price target and a buy rating on the shares.
05/23/17
STFL
05/23/17
NO CHANGE
Target $20
STFL
Buy
TherapeuticsMD scheduled to meet FDA on June 14, says Stifel
Stifel analyst Annabel Samimy says TherapeuticsMD's Type A meeting with the FDA to discuss last month's Complete Response Letter is scheduled for June 14. The analyst sees two likely scenarios from the meeting. The first has TherapeuticsMD seeking class labeling with a Phase 4 post-marketing study to eventually amend the label. And the second has the company seeking an appeal should FDA hold firm in the 12-month safety requirement to justify a differentiated label. Samimy is "convinced" that TX-004HR remains approvable and she keeps a Buy rating on the shares with a $20 price target.
05/09/17
JEFF
05/09/17
NO CHANGE
Target $15
JEFF
Buy
TherapeuticsMD price target lowered to $15 from $18 at Jefferies
Jefferies analyst Matthew Andrews lowered his price target for TherapeuticsMD to $15 citing a lower probability of success for TX-004HR following the Complete Response Letter. The analyst, with a 55% probability of approval now, believes the FDA's endometrial safety concerns appear addressable. If FDA agrees to approve '004 with a post-approval study, it could obtain a class label with boxed warning, Andrews tells investors in a research note. He keeps a Buy rating on TherapeuticsMD.
05/09/17
OPCO
05/09/17
DOWNGRADE
OPCO
Perform
TherapeuticsMD downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Jay Olson downgraded TherapeuticsMD to Perform saying he's surprised by the FDA's request for long-term safety data. The analyst prefers to move to the sidelines amid uncertainty resulting from the Complete Response Letter.

TODAY'S FREE FLY STORIES

EGRX

Eagle Pharmaceuticals

$70.04

-2.76 (-3.79%)

12:37
07/26/17
07/26
12:37
07/26/17
12:37
Hot Stocks
Breaking Hot Stocks news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

EGRX

Eagle Pharmaceuticals

$70.04

-2.76 (-3.79%)

12:36
07/26/17
07/26
12:36
07/26/17
12:36
Hot Stocks
Breaking Hot Stocks news story on Eagle Pharmaceuticals »

Eagle says FDA asks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

CMG

Chipotle

$346.19

-2.427 (-0.70%)

12:36
07/26/17
07/26
12:36
07/26/17
12:36
Periodicals
Expert calls Chipotle's FDA criminal subpoena 'highly unusual,' NY Post reports »

The subpoena from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGRX

Eagle Pharmaceuticals

$70.04

-2.76 (-3.79%)

12:36
07/26/17
07/26
12:36
07/26/17
12:36
Hot Stocks
Eagle Pharmaceuticals receives complete response letter from FDA on Ryanodex »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

IVPAF

Ivanhoe Mines

$3.89

0.1263 (3.36%)

12:33
07/26/17
07/26
12:33
07/26/17
12:33
Conference/Events
Ivanhoe Mines management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

WYNN

Wynn Resorts

$138.98

0.45 (0.32%)

12:30
07/26/17
07/26
12:30
07/26/17
12:30
Options
Wynn Resorts calls active as shares fall on earnings »

Wynn Resorts calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGRX

Eagle Pharmaceuticals

$70.04

-2.76 (-3.79%)

12:29
07/26/17
07/26
12:29
07/26/17
12:29
Hot Stocks
Breaking Hot Stocks news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

FLY

Fly Leasing

$13.94

-0.04 (-0.29%)

12:27
07/26/17
07/26
12:27
07/26/17
12:27
Conference/Events
Fly Leasing management to meet with RBC Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 10

    Aug

SIRI

SiriusXM

$5.39

0.01 (0.19%)

12:25
07/26/17
07/26
12:25
07/26/17
12:25
Options
Sirius XM call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 05

    Sep

AKAM

Akamai

$53.28

0.91 (1.74%)

12:24
07/26/17
07/26
12:24
07/26/17
12:24
Conference/Events
Akamai management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 27

    Jul

  • 08

    Aug

  • 05

    Sep

MPC

Marathon Petroleum

$56.44

0.42 (0.75%)

12:20
07/26/17
07/26
12:20
07/26/17
12:20
Hot Stocks
Marathon Petroleum raises quarterly dividend 11% to 40c per share »

Marathon Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

$NSD

NASDAQ Market Internals

12:17
07/26/17
07/26
12:17
07/26/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
07/26/17
07/26
12:16
07/26/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSCO

Tractor Supply

$53.53

2.01 (3.90%)

12:15
07/26/17
07/26
12:15
07/26/17
12:15
Options
Tractor Supply put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

BA

Boeing

$230.75

18.29 (8.61%)

, KO

Coca-Cola

$45.36

0.1151 (0.25%)

12:03
07/26/17
07/26
12:03
07/26/17
12:03
General news
On The Fly: Top stock stories at midday »

Stocks opened in positive…

BA

Boeing

$230.75

18.29 (8.61%)

KO

Coca-Cola

$45.36

0.1151 (0.25%)

T

AT&T

$37.84

1.62 (4.47%)

AMD

AMD

$14.11

-0.05 (-0.35%)

TXN

Texas Instruments

$81.39

0.47 (0.58%)

GLW

Corning

$30.29

-1.84 (-5.73%)

GD

General Dynamics

$194.50

-9.06 (-4.45%)

AMGN

Amgen

$180.89

-0.17 (-0.09%)

IRBT

iRobot

$87.90

-2.48 (-2.74%)

AMED

Amedisys

$59.41

0.61 (1.04%)

AFAM

Almost Family

$56.70

-0.15 (-0.26%)

HLS

HealthSouth

$43.48

-2.24 (-4.90%)

KND

Kindred Healthcare

$9.70

-1.5 (-13.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 30

    Jul

  • 01

    Aug

  • 04

    Aug

  • 07

    Aug

  • 08

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 17

    Aug

  • 23

    Aug

  • 23

    Aug

  • 29

    Aug

  • 07

    Sep

  • 08

    Sep

  • 14

    Sep

  • 16

    Nov

  • 03

    Feb

  • 17

    May

GSM

Ferroglobe

$12.90

0.32 (2.54%)

12:02
07/26/17
07/26
12:02
07/26/17
12:02
Hot Stocks
Ferroglobe has not received regulatory approvals from Spain's water authority »

Ferroglobe announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

MNGA

Magnegas

$0.75

-0.1699 (-18.47%)

12:01
07/26/17
07/26
12:01
07/26/17
12:01
Hot Stocks
USPTO issues MagneGas patent on MagneCule theory »

MagneGas Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBLU

JetBlue

$22.77

0.01 (0.04%)

12:00
07/26/17
07/26
12:00
07/26/17
12:00
Options
Post-earnings option play opened in JetBlue »

Post-earnings option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

BA

Boeing

$229.65

17.1924 (8.09%)

11:54
07/26/17
07/26
11:54
07/26/17
11:54
Hot Stocks
Boeing seeing Pentagon demand above Trump's FY18 budget request »

In its Defense, Space…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 07

    Aug

WY

Weyerhaeuser

$34.11

-0.014 (-0.04%)

11:50
07/26/17
07/26
11:50
07/26/17
11:50
Options
Call buyer in Weyerhaeuser ahead of earnings »

Call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

LVMUY

LVMH

$51.12

-0.02 (-0.04%)

11:49
07/26/17
07/26
11:49
07/26/17
11:49
Earnings
LVMH reports first half revenue up 15% to EUR 19.7B »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$229.61

17.15 (8.07%)

11:47
07/26/17
07/26
11:47
07/26/17
11:47
Hot Stocks
Boeing has over '700 firm orders in backlog' for 787 Dreamliner program »

Boeing said its 787…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 07

    Aug

FB

Facebook

$165.28

-0.72 (-0.43%)

11:45
07/26/17
07/26
11:45
07/26/17
11:45
Technical Analysis
Technical Earnings Preview: Facebook in strong uptrend before news »

The stock has been in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Sep

CF

CF Industries

$29.01

-1.16 (-3.84%)

11:45
07/26/17
07/26
11:45
07/26/17
11:45
Options
CF Industries call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

11:45
07/26/17
07/26
11:45
07/26/17
11:45
General news
Treasury's $15 B 2-year FRN garnered decent results »

Treasury's $15 B…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.